1l Pembrolizumab (Pembro) Versus Chemotherapy (Chemo) For Choice-Of-Carboplatin Patients With Advanced Urothelial Carcinoma (Uc) In Keynote-361.
JOURNAL OF CLINICAL ONCOLOGY（2021）
摘要
450Background: 1L pembro is approved in advanced UC for cisplatin-ineligible pts with PD-L1 combined positive score (CPS) ≥10 and any platinum-ineligible pts regardless of CPS in the United States ...
更多查看译文
关键词
advanced urothelial carcinoma,urothelial carcinoma,chemotherapy,pembrolizumab,choice-of-carboplatin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要